Received Jun 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | cb25n | — |
Administration of only the liquid component; Administration of only the liquid component; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 16-year-old female patient who received Men ABCWY NVS (Penmenvy) suspension for injection in pre-filled syringe (batch number cb25n with expiry date 07-JAN-2027) for prophylaxis. On 15-JUN-2026, the patient received the 1st dose of Penmenvy. On 15-JUN-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate dose of vaccine administered (Verbatim: Administration of only the liquid component) and inappropriate preparation of medication (Verbatim: Administration of only the liquid component). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-JUN-2026 A healthcare professional (HCP) reported that on 15-JUN-2026, the patient received an incomplete dose of Penmenvy, with only the liquid component given. The batch number was not provided upon follow- up with the reporter.